Diflucan and Tyvaso drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Diflucan (fluconazole) and Tyvaso (treprostinil sodium). Common drug interactions include nasal congestion among females and angina pectoris among males.

The phase IV clinical study analyzes what interactions people have when they take Diflucan and Tyvaso. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Diflucan?

Diflucan has active ingredients of fluconazole. It is often used in vaginal yeast infection. eHealthMe is studying from 28,471 Diflucan users. Check the latest studies of Diflucan.

What is Tyvaso?

Tyvaso has active ingredients of treprostinil sodium. eHealthMe is studying from 37,941 Tyvaso users. Check the latest studies of Tyvaso.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 18, 2026

19 people who take Diflucan and Tyvaso together, and have interactions are studied.

Diflucan and Tyvaso drug interactions.

What are the common drug interactions of Diflucan and Tyvaso, by gender? *:

female:

  1. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  2. Fungal infection
  3. Headache (pain in head)
  4. Malaise (a feeling of general discomfort or uneasiness)
  5. Oral candidiasis (fungal infection of mouth)
  6. Abscess (pus)
  7. Blood pressure increased
  8. Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)
  9. Drug hypersensitivity
  10. Eye pain

male:

  1. Angina pectoris (chest pain due to ischemia of the heart muscle)
  2. Ascites (accumulation of fluid in the abdominal cavity)
  3. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  4. Chronic hepatic failure (long lasting liver failure)
  5. Decreased appetite
  6. Diarrhoea
  7. Malaise (a feeling of general discomfort or uneasiness)
  8. Nausea (feeling of having an urge to vomit)
  9. Oral candidiasis (fungal infection of mouth)
  10. Weight decreased

What are the common drug interactions of Diflucan and Tyvaso, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Dyspnoea (difficult or laboured respiration)
  2. Febrile neutropenia (fever with reduced white blood cells)
  3. Headache (pain in head)
  4. Lymphoma (cancer that begins in immune system cells)

50-59:

  1. Abdominal pain upper
  2. Cardiac failure
  3. Dyspnoea (difficult or laboured respiration)
  4. Dyspnoea exertional (breathlessness or shortness of breath)
  5. Fluid retention (an abnormal accumulation of fluid in the blood)
  6. Oedema peripheral (superficial swelling)
  7. Pulmonary hypertension (increase in blood pressure in the lung artery)
  8. Weight increased
  9. Chronic hepatic failure (long lasting liver failure)
  10. Abscess (pus)

60+:

  1. Diarrhoea
  2. Malaise (a feeling of general discomfort or uneasiness)
  3. Back injury
  4. Back pain
  5. Burning sensation
  6. Cardiomegaly (increased size of heart than normal)
  7. Catheter site discharge
  8. Contusion (a type of hematoma of tissue in which capillaries)
  9. Dehydration (dryness resulting from the removal of water)
  10. Dyspnoea (difficult or laboured respiration)

What are the existing conditions these people have? *

  1. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 15 people, 78.95%
  2. Oral Candidiasis (fungal infection of mouth): 9 people, 47.37%
  3. Pulmonary Hypertension (increase in blood pressure in the lung artery): 6 people, 31.58%
  4. Pharyngitis Streptococcal (inflammation of the pharynx caused by infection from. streptococcus): 5 people, 26.32%
  5. Multiple Allergies (allergy to multiple agents): 5 people, 26.32%
  6. Infection: 5 people, 26.32%
  7. Fungal Infection: 2 people, 10.53%
  8. Sinus Disorder (disease of sinus): 1 person, 5.26%
  9. Gastritis (inflammation of stomach): 1 person, 5.26%
  10. Cardiac Failure: 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Diflucan and Tyvaso?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Diflucan and Tyvaso:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Diflucan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Tyvaso:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Diflucan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tyvaso and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on fluconazole and treprostinil sodium (the active ingredients of Diflucan and Tyvaso, respectively), and Diflucan and Tyvaso (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: